Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
2020 · Molecular Therapy · 55 citations
https://doi.org/10.1016/j.ymthe.2020.07.017
R
Renee B. Chang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
305
Citations
8
h-index
8
i10-index
Renee B. Chang is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics. The author has an h-index of 8, co-authored 36 publications.
ORCID: 0000-0001-6298-7005Papers by this author
worksCancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
2023 · Science Immunology · 46 citations
https://doi.org/10.1126/sciimmunol.adj5097
Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer
2024 · Cell Reports Medicine · 21 citations
https://doi.org/10.1016/j.xcrm.2024.101397
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat